Literature DB >> 17174996

Phenylalanine(90) and phenylalanine(93) are crucial amino acids within the estrogen binding site of the human UDP-glucuronosyltransferase 1A10.

Athena Starlard-Davenport1, Yan Xiong, Stacie Bratton, Anna Gallus-Zawada, Moshe Finel, Anna Radominska-Pandya.   

Abstract

Human UDP-glucuronosyltransferase 1A10 has been identified as the major isoform involved in the biotransformation of a wide range of phenolic substrates, including native estrogens and their oxidized metabolites. Our recent studies point to the F(90)-M(91)-V(92)-F(93) amino acid motif of UGT1A10, which was identified using photoaffinity labeling followed by LC-MS/MS analysis, as a key determinant of the binding of phenolic substrates. In this report, we have evaluated the role of F(90), V(92), and F(93) in the recognition of estrogens by UGT1A10 using site-directed mutagenesis. Kinetic studies using five mutants revealed that F(90) and F(93) are critical residues for the recognition of all estrogen substrates. The substitution of F(90) with alanine totally abolished the activity of this enzyme toward all the estrogens investigated. Overall, sequential removal for the aromatic ring (F to L) and of the hydrophobic chain (F to A and V to A) from amino acids 90, 92, and 93 effectively alters estrogen recognition. This demonstrates that individual features of the native and hydroxylated estrogens determine the specific binding properties of the compound within the binding site of the human UGT1A10 and the mutants. The resulting activities are completely abolished, unchanged, increased, or decreased depending on the structures of both the mutant and the substrate. The novel identification of UGT1A10 as the major isoform involved in the glucuronidation of all estrogens and the discovery of the importance of the FMVF motif in the binding of steroids will help to elucidate the molecular mechanism of glucuronidation, resulting in the design of more effective estrogen-based therapies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17174996      PMCID: PMC1829494          DOI: 10.1016/j.steroids.2006.11.016

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  26 in total

Review 1.  Estrogen metabolism by conjugation.

Authors:  R Raftogianis; C Creveling; R Weinshilboum; J Weisz
Journal:  J Natl Cancer Inst Monogr       Date:  2000

Review 2.  Role of DNA adducts in hormonal carcinogenesis.

Authors:  J G Liehr
Journal:  Regul Toxicol Pharmacol       Date:  2000-12       Impact factor: 3.271

3.  Inactivation of the pure antiestrogen fulvestrant and other synthetic estrogen molecules by UDP-glucuronosyltransferase 1A enzymes expressed in breast tissue.

Authors:  Sarah Chouinard; Mélanie Tessier; Gabrielle Vernouillet; Sylvain Gauthier; Fernand Labrie; Olivier Barbier; Alain Bélanger
Journal:  Mol Pharmacol       Date:  2005-12-08       Impact factor: 4.436

4.  Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs). UGT1A9 is more resistant to detergent inhibition than other UGTs and was purified as an active dimeric enzyme.

Authors:  Mika Kurkela; J Arturo García-Horsman; Leena Luukkanen; Saila Mörsky; Jyrki Taskinen; Marc Baumann; Risto Kostiainen; Jouni Hirvonen; Moshe Finel
Journal:  J Biol Chem       Date:  2002-11-14       Impact factor: 5.157

5.  Glucuronidation of the dietary fatty acids, phytanic acid and docosahexaenoic acid, by human UDP-glucuronosyltransferases.

Authors:  Joanna M Little; Lisa Williams; Jing Xu; Anna Radominska-Pandya
Journal:  Drug Metab Dispos       Date:  2002-05       Impact factor: 3.922

6.  Gastrointestinally distributed UDP-glucuronosyltransferase 1A10, which metabolizes estrogens and nonsteroidal anti-inflammatory drugs, depends upon phosphorylation.

Authors:  Nikhil K Basu; Shigeki Kubota; Meselhy R Meselhy; Marco Ciotti; Bhabadeb Chowdhury; Masao Hartori; Ida S Owens
Journal:  J Biol Chem       Date:  2004-04-26       Impact factor: 5.157

7.  Glucuronidation of oxidized fatty acids and prostaglandins B1 and E2 by human hepatic and recombinant UDP-glucuronosyltransferases.

Authors:  Joanna M Little; Mika Kurkela; Julia Sonka; Sirkku Jäntti; Raimo Ketola; Stacie Bratton; Moshe Finel; Anna Radominska-Pandya
Journal:  J Lipid Res       Date:  2004-07-01       Impact factor: 5.922

8.  Glucuronidation of anabolic androgenic steroids by recombinant human UDP-glucuronosyltransferases.

Authors:  Tiia Kuuranne; Mika Kurkela; Mario Thevis; Wilhelm Schänzer; Moshe Finel; Risto Kostiainen
Journal:  Drug Metab Dispos       Date:  2003-09       Impact factor: 3.922

9.  Steroid sulfatase and estrogen sulfotransferase in normal human tissue and breast carcinoma.

Authors:  Takashi Suzuki; Yasuhiro Miki; Taisuke Nakata; Yukimasa Shiotsu; Shiro Akinaga; Kengo Inoue; Takanori Ishida; Michio Kimura; Takuya Moriya; Hironobu Sasano
Journal:  J Steroid Biochem Mol Biol       Date:  2003-09       Impact factor: 4.292

Review 10.  Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis.

Authors:  W Yue; R J Santen; J-P Wang; Y Li; M F Verderame; W P Bocchinfuso; K S Korach; P Devanesan; R Todorovic; E G Rogan; E L Cavalieri
Journal:  J Steroid Biochem Mol Biol       Date:  2003-09       Impact factor: 4.292

View more
  12 in total

Review 1.  First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics.

Authors:  Baojian Wu; Kaustubh Kulkarni; Sumit Basu; Shuxing Zhang; Ming Hu
Journal:  J Pharm Sci       Date:  2011-04-11       Impact factor: 3.534

2.  Prevalence of the UGT1A1*28 promoter polymorphism and breast cancer risk among African American women in Memphis, TN.

Authors:  Alana Smith; Cheryl D Cropp; Gregory Vidal; Elizabeth Pritchard; Jennifer Cordero; Claire Simpson; Athena Starlard-Davenport
Journal:  Cancer Health Disparities       Date:  2019-08-19

3.  Phenylalanine 93 of the human UGT1A10 plays a major role in the interactions of the enzyme with estrogens.

Authors:  Camilla Höglund; Nina Sneitz; Anna Radominska-Pandya; Liisa Laakonen; Moshe Finel
Journal:  Steroids       Date:  2011-08-09       Impact factor: 2.668

4.  Analysis of R- and S-hydroxywarfarin glucuronidation catalyzed by human liver microsomes and recombinant UDP-glucuronosyltransferases.

Authors:  Stacie M Bratton; Carrie M Mosher; Farid Khallouki; Moshe Finel; Michael H Court; Jeffery H Moran; Anna Radominska-Pandya
Journal:  J Pharmacol Exp Ther       Date:  2011-10-04       Impact factor: 4.030

5.  Role of human UDP-glucuronosyltransferases in the biotransformation of the triazoloacridinone and imidazoacridinone antitumor agents C-1305 and C-1311: highly selective substrates for UGT1A10.

Authors:  Barbara Fedejko-Kap; Stacie M Bratton; Moshe Finel; Anna Radominska-Pandya; Zofia Mazerska
Journal:  Drug Metab Dispos       Date:  2012-06-01       Impact factor: 3.922

6.  Novel identification of UDP-glucuronosyltransferase 1A10 as an estrogen-regulated target gene.

Authors:  Athena Starlard-Davenport; Beverly Lyn-Cook; Anna Radominska-Pandya
Journal:  Steroids       Date:  2007-09-29       Impact factor: 2.668

7.  Identification of UDP-glucuronosyltransferase 1A10 in non-malignant and malignant human breast tissues.

Authors:  Athena Starlard-Davenport; Beverly Lyn-Cook; Anna Radominska-Pandya
Journal:  Steroids       Date:  2008-02-03       Impact factor: 2.668

8.  Dopamine is a low-affinity and high-specificity substrate for the human UDP-glucuronosyltransferase 1A10.

Authors:  Katriina Itäaho; Michael H Court; Päivi Uutela; Risto Kostiainen; Anna Radominska-Pandya; Moshe Finel
Journal:  Drug Metab Dispos       Date:  2008-12-30       Impact factor: 3.922

9.  Identification of hydroxywarfarin binding site in human UDP glucuronosyltransferase 1a10: phenylalanine90 is crucial for the glucuronidation of 6- and 7-hydroxywarfarin but not 8-hydroxywarfarin.

Authors:  Grover P Miller; Cheryl F Lichti; Agnieszka K Zielinska; Anna Mazur; Stacie M Bratton; Anna Gallus-Zawada; Moshe Finel; Jeffery H Moran; Anna Radominska-Pandya
Journal:  Drug Metab Dispos       Date:  2008-08-25       Impact factor: 3.922

10.  The Influence of LepR Tyrosine Site Mutations on Mouse Ovary Development and Related Gene Expression Changes.

Authors:  Xiaoyu Tu; Zhichao Kuang; Xia Gong; Yan Shi; Lin Yu; Huijuan Shi; Jian Wang; Zhaogui Sun
Journal:  PLoS One       Date:  2015-11-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.